Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANAPTYSBIO, INC Director's Dealing 2018

Apr 18, 2018

32596_dirs_2018-04-18_a1c95349-66eb-40bb-932d-583cda78fa82.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2018-04-16

Reporting Person: Lydon Nicholas (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-04-16 Common Stock S 2600 $84.1846 Disposed 301506 Direct
2018-04-16 Common Stock S 10310 $85.1107 Disposed 291196 Direct
2018-04-16 Common Stock S 1390 $86.1532 Disposed 289806 Direct
2018-04-16 Common Stock S 9425 $87.4632 Disposed 280381 Direct
2018-04-16 Common Stock S 4250 $88.2982 Disposed 276131 Direct
2018-04-16 Common Stock S 2803 $89.4154 Disposed 273328 Direct
2018-04-16 Common Stock S 2222 $90.2561 Disposed 271106 Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.

F2: Represents the aggregate of sales effected on the same day at different prices.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $83.69 to $84.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $84.75 to $85.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $85.75 to $86.73 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F6: Represents the weighted average sales price per share. The shares sold at prices ranging from $86.91 to $87.895 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F7: Represents the weighted average sales price per share. The shares sold at prices ranging from $87.91 to $88.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F8: Represents the weighted average sales price per share. The shares sold at prices ranging from $88.91 to $89.87 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F9: Represents the weighted average sales price per share. The shares sold at prices ranging from $89.93 to $90.69 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.